Human placental growth hormone increases expression of the p85 regulatory unit of phosphatidylinositol 3-kinase and triggers severe insulin resistance in skeletal muscle.
暂无分享,去创建一个
J. Friedman | J. Shao | L. Qiao | B. Draznin | W. Leitner | L. Barbour | Boris Draznin | Jacob E Friedman | Liping Qiao | Jianhua Shao | Linda A Barbour | Wayne Leitner | Marianne Anderson | Marianne S. Anderson
[1] S. Handwerger,et al. The Roles of Placental Growth Hormone and Placental Lactogen in the Regulation of Human Fetal Growth and Development , 2000, Journal of pediatric endocrinology & metabolism : JPEM.
[2] J. Friedman,et al. Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): evidence for increased serine/threonine phosphorylation in pregnancy and GDM. , 2000, Diabetes.
[3] J. Friedman,et al. Human placental growth hormone causes severe insulin resistance in transgenic mice. , 2002, American journal of obstetrics and gynecology.
[4] Kohjiro Ueki,et al. Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. , 2002, The Journal of clinical investigation.
[5] M. Kasuga,et al. Phosphoinositide 3-kinase is required for insulin-induced but not for growth hormone- or hyperosmolarity-induced glucose uptake in 3T3-L1 adipocytes. , 1997, Molecular endocrinology.
[6] T. Sasaoka,et al. Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes. , 2001, Diabetes.
[7] Bei B. Zhang,et al. Pi 3-kinase and its up- and down-stream modulators as potential targets for the treatment of type II diabetes. , 2002, Frontiers in bioscience : a journal and virtual library.
[8] J. Friedman,et al. Physiologic and molecular alterations in carbohydrate metabolism during pregnancy and gestational diabetes mellitus. , 2000, Clinical obstetrics and gynecology.
[9] J. Guibourdenche,et al. Physiological role of human placental growth hormone , 1998, Molecular and Cellular Endocrinology.
[10] R. Anthony,et al. Placental Lactogen and Growth Hormone , 1998 .
[11] Y. Matsuzawa,et al. Increased insulin sensitivity and hypoglycaemia in mice lacking the p85α subunit of phosphoinositide 3–kinase , 1999, Nature Genetics.
[12] J. Pessin,et al. Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways , 2002, Diabetologia.
[13] D. Le Roith,et al. Recent advances in our understanding of insulin action and insulin resistance. , 2001, Diabetes care.
[14] P. Lacy,et al. Effect of homologous placental lactogens, prolactins, and growth hormones on islet B-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy. , 1993, Endocrinology.
[15] J. Kopchick,et al. Growth hormone (GH), GH receptor, and signal transduction. , 2000, Molecular genetics and metabolism.
[16] F. Dominici,et al. Growth Hormone-Induced Alterations in the Insulin-Signaling System , 2002, Experimental biology and medicine.
[17] F. Dominici,et al. Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH-transgenic mice. , 1999, American journal of physiology. Endocrinology and metabolism.
[18] J. Friedman,et al. Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. , 1999, Diabetes.
[19] J. Friedman,et al. TNF-α Is a Predictor of Insulin Resistance in Human Pregnancy , 2002 .
[20] T. Wagner,et al. Expression of the human growth hormone variant gene in cultured fibroblasts and transgenic mice. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[21] G. Hennen,et al. Placental growth hormone variant: assay and clinical aspects , 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[22] M. Ridderstråle,et al. Tyrosine phosphorylation of the growth hormone (GH) receptor and Janus tyrosine kinase-2 is involved in the insulin-like actions of GH in primary rat adipocytes. , 1995, Endocrinology.
[23] C. Kahn,et al. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. , 1997, The Journal of clinical investigation.
[24] J. Friedman,et al. Phosphatidylinositol 3-kinase redistribution is associated with skeletal muscle insulin resistance in gestational diabetes mellitus. , 2002, Diabetes.
[25] Khan Ah,et al. Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways. , 2002 .